Medtronic Reports Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
- Wall Street ends down as expectations of Hormuz deal fade
- JPMorgan lifts S&P 500 target to 8,000 on strong earnings
- Nvidia and Wall Street giants plan $500B AI funding deal, FT reports
- Jefferies cuts Apple rating as higher-priced iPhone roadmap looks difficult
- Oil climbs 5% as Iran, US both demand compensation and Hormuz hopes fade
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
Medtronic's (MDT) Weak Margins Spur PT Reduction - Leerink Partners
March 2, 2016 6:41 AM ESTLeerink Partners analyst, Danielle Antalffy, cut her PT on Medtronic (NYSE: MDT) as sales growth was offset by weaker margins. PT goes to $82 from $84 and Market Perform rating remains unchanged.
MDT shares traded lower yesterday driven by less positive operating leverage than expected, as... More
Buy Medtronic (MDT) Weakness, Says Deutsche Bank
March 1, 2016 3:02 PM ESTDeutsche Bank earlier reiterated a Buy rating on Medtronic, Inc. (NYSE: MDT) with a price target of $90. Analyst Kristen Stewart said investors should buy weakness.
The analyst explained, "We continue to rate MDT a Buy. Why? We see a number of recently and... More
Needham & Company Cuts Price Target on Medtronic (MDT) as 3Q Revenue Misses Mark
March 1, 2016 11:50 AM ESTNeedham & Company maintained a Buy rating on Medtronic, Inc. (NYSE: MDT), and cut the price target to $88.00 (from $91.00), following the company's 3Q earnings report. Revenue was reported at $6.934B vs. the consensus of $6.987B. Adjusted EPS was reported at $1.06, in-line with consensus estimates. MDT... More
Medtronic (MDT) Reports In-Line Q3 EPS
March 1, 2016 6:47 AM ESTMedtronic (NYSE: MDT) reported Q3 EPS of $1.06, in-line with the analyst estimate of $1.06. Revenue for the quarter came in at $6.93 billion versus the consensus estimate of $6.99 billion.
GUIDANCE:
Medtronic still sees FY16 EPS of $4.36 - $4.40, versus the consensus of $4.38.
For earnings history and earnings-related data on Medtronic (MDT) click here.
... More